Further analysis found the higher the tumor grade, the higher PDK1 expression in ACC/CESC/PRAD patients (P < 0.05, Fig 6J-6L), with the detailed analysis results recorded in S8 Table. This evidence concerns the gene PDK1 and prostate adenocarcinoma.